Typicality: | 0.410 |
Saliency: | 0.375 |
in 2016 | 5 | temporal |
to prevent human papillomavirus | 3 | purpose |
to protect girls | 2 | purpose |
vaccine → be developed by → merck | 38 |
vaccine → be introduced by → merck | 3 |
vaccine → be proposed by → merck | 3 |
vaccine → developed by → merck | 3 |
negative | neutral | positive |
0.148 | 0.594 | 0.258 |
Raw frequency | 47 |
Normalized frequency | 0.375 |
Modifier score | 0.500 |
Perplexity | 106.665 |